BioBlast Pharma
is a clinical-stage biotechnology company that focuses on the development of clinical therapies for rare genetic diseases... Read moreBioBlast Pharma
is a clinical-stage biotechnology company that focuses on the development of clinical therapies for rare genetic diseases... Read more
News
Apr 02, 2019
The Pharma Letter
BioBlast Pharma : BRIEF-Enlivex raises $5.4 million along with completing Bioblast merger
Mar 28, 2019
CTech
BioBlast Pharma : Cell Immunotherapy Company Enlivex Merges With Nasdaq-Listed Bioblast, Raises $5.3 Million
Mar 06, 2019
4-traders
BioBlast Pharma : Bioblast Announces Effectiveness of Eight to One Reverse Split
Feb 19, 2019
4-traders
BioBlast Pharma : Bioblast Pharma Announces Sale of its Trehalose Clinical Development Programs to Seelos Therapeutics
Feb 15, 2019
4-traders
BioBlast Pharma : Bioblast Pharma Announces Collaboration with Team Sanfilippo to Evaluate Trehalose for the Treatment of Sanfilippo Syndrome
Jan 12, 2019
GlobeNewswire
Press Release: BioBlast Pharma : Bioblast Pharma Ltd. Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders' Equity Non-Compliance
Jan 11, 2019
StreetInsider
Press Release: BioBlast Pharma : Bioblast Pharma Ltd. Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders' Equity Non-Compliance
Jan 11, 2019
StreetInsider
Press Release: BioBlast Pharma : Bioblast Pharma Ltd. Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders' Equity Non-Compliance
Jan 11, 2019
streetinsider
BioBlast Pharma : BioBlast Pharma (ORPN) Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders' Equity Non-Compliance
Nov 20, 2018
FierceBiotech
BioBlast Pharma : Enlivex to merge with BioBlast, bagging Nasdaq listing
BioBlast Pharma Competitors
1
2
3
4
5
6
7
8
9
10